SCHEMBL10270217

SCHEMBL10270217

Nc1cccc(C(C[N+](=O)[O-])C2(c3ccc(Cl)cc3)CCC2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.38
ALOX15 P16050 2/20 0.38
TSHR P16473 2/20 0.38
TP53 P04637 1/20 0.38
SLC6A3 Q01959 8/20 0.38
SLC6A4 P31645 7/20 0.38
PDE7A Q13946 1/20 0.36
SLC6A2 P23975 2/20 0.35
CHRM2 P08172 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
HTR2A P28223 1/20 0.35
OPRK1 P41145 1/20 0.35
HTR2B P41595 1/20 0.35
KCNH2 Q12809 1/20 0.35
MAPT P10636 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPK1 P28482 2/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL622677 0.84 CNR1 (0.39) CCR1CNR1
SCHEMBL10270219 0.83 CYP3A4 (0.43) CYP3A4ALOX15TSHRTP53SLC6A3
SCHEMBL622964 0.75 CYP3A4 (0.43) CYP3A4ALOX15TSHRTP53SLC6A3
SCHEMBL10270218 0.72 DRD2 (0.43) CYP3A4ALOX15TSHRTP53SLC6A3
SCHEMBL623500 0.70 CYP3A4 (0.42) CYP3A4ALOX15TSHRTP53SLC6A3
SCHEMBL868291 0.68 TP53 (0.40) CYP3A4ALOX15TSHRTP53SLC6A3
SCHEMBL31088583 0.68 ALDH1A1 (0.37) SLC6A4SLC6A2MAPTALDH1A1LMNA
SCHEMBL2606 0.63 SLC6A4 (0.54) CYP3A4ALOX15TSHRTP53SLC6A3
Hydrochloric Acid SCHEMBL1161 0.62 CYP3A4 (0.54) CYP3A4ALOX15TSHRTP53SLC6A3
SCHEMBL18623178 0.62 CA1 (0.55) CYP3A4ALOX15TSHRSLC6A3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020130-A1 PHENALKYLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBOTT GMBH & CO. KG (DE) 2012-02-16 WO disclosed